Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F18MK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,332
Award facts
- Contract value 100% obligated
- $101,331.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $101,331.84 to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials on November 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. The delivery order is scheduled for completion by December 16, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania.
This award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Ocrevus is a specialty medication used for multiple sclerosis treatment, exemplifying the company's role in delivering specialized pharmaceutical products essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F18MK?
SPE2DR26F18MK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F18MK worth?
The government has obligated $101,332 on SPE2DR26F18MK.
Is contract SPE2DR26F18MK an order under another contract?
Yes. SPE2DR26F18MK is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18MK competed?
The extent of competition for SPE2DR26F18MK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award